Meanwhile, China normalises its zero-COVID policy
Suddenly, in just two months, China has loosened its restrictive social and mobility-based policies. This normalisation is reactivating mobility in the country, and we’re likely to see an upturn in economic activity; the market consensus once again envisages growth more in line with the pre-COVID situation (an annual 5%).
After two years during which both the Chinese stock market and the emerging stock markets have undergone significant falls, the last months of 2022 and the beginning of this year have seen a considerable change in trend. Without any great degree of certainty as to the performance of the two assets in the short term, over longer time frames we believe that emerging equities should offer good returns, given the current depressed valuation levels (11x P/E forecast next 12m), in contrast to the more rigorous valuations of Western markets such as the US (17x).
After a very poor 2022 for most assets, 2023 has begun on a more favourable note. While it’s true that Portfolio Management has slightly reduced its equity investment levels, in general we remain invested. Despite the recent increases, our job is less difficult today than it was in early 2022, when the vast majority of assets were expensive from a valuation point of view. Despite the strong performance in recent months, many fixed income assets offer value and favourable medium-term return prospects. Meanwhile equity has become cheaper in the wake of the falls in 2022, which means that, when it comes to building portfolios, the prospects for returns are significantly better, with particular emphasis on the most conservative portfolios, mostly made up of fixed income assets. For example, in the portfolios managed by MoraBanc we’re over-weighting assets such as bonds linked to short-term inflation, emerging equity and small Japanese companies; these are assets that are trading at lower levels in a historical context, but we think they have good prospects in terms of their future performance.